Tuberculosis: Our Impact

Afghanistan is one of 22 countries that have been designated as having a high burden of tuberculosis (TB). Each year, roughly 11,000 Afghans die from TB--many of these deaths occur in rural regions where residents have limited access to TB screening and treatment.

The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, led by Management Sciences for Health, in collaboration with the World Health Organization (WHO) and Stop TB partners, is co-hosting the 2nd Africa Tuberculosis (TB) Regional Conference on Management of TB Medicines in Zanzibar, Tanzania, from December 5 – 7, 2012.The Africa regional TB conference focuses on identifying and prioritizing country specific challenges for the management of TB medicines.

Juan-Carlos Alegre

Monitoring and evaluation (M&E) systems have played a critical role in advancing the field of global health, from applying quantitative and qualitative methods in collecting and using health data, to informing decision making, applying rigorous evaluations in assessing program effectiveness, and designing and conducting operational research that address implementation challenges.

The Management Sciences for Health (MSH) global team of over 2,300 people from more than 70 nations is commemorating World AIDS Day 2012 in over 30 country offices around the world, including Nigeria, Democratic Republic of the Congo (DRC), Afghanistan, Ethiopia, South Africa, Uganda, Haiti, and the United States.On World AIDS Day, MSH Nigeria, in collaboration with the Discovery Channel Global Education Partnership, Chevron, and Access Bank Plc, will be hosting a launch of the award-winning film titled “INSIDE STORY: The Science of HIV/AIDS” in Lagos, Nigeria.

Please join MSH and partners during these featured events at the 43rd Union World Conference on Lung Health.Follow the conference on Twitter @MSHHealthImpact with hashtag #Kuala2012.Health Systems Innovation through Pharmaceutical ManagementWorkshop 03: Transition to Sustainable Pharmaceutical Management Systems for TBWednesday, 14 November | 09:00–17:00 | Room 407Organized by MSH and the Global Drug Facility (GDF)MSH and the GDF will share experiences and strategies for improving systems and ensuring sustainability and quality of TB pharmaceutical services delivery.

Homa Bay TB team, MSF, and SIAPS collaboration. (Photo credit: MSH)Successful treatment of tuberculosis (TB) is one of the key indicators of a TB Control Program’s performance and essential to containing the emergence of anti-TB drug resistance. Multi-drug resistant TB (MDR-TB) treatment requires medicines that are expensive, involve longer treatment regimens, are toxic, and can cause patients to have severe side effects.

Management Sciences for Health takes pride in announcing that on September 30, 2012, it was awarded a contract by the U.S. Agency for International Development (USAID) to continue its project Grant Management Solutions (GMS) with 25 partners. The initial three-year term of the new contract may be extended up to an additional two years, and has a ceiling value of $99.9 million.

Management Sciences for Health and its fellow Global AIDS Policy Partnership (GAPP) organizations wrote this letter to US Global AIDS Coordinator Eric Goosby to thank him for the opportunity to provide input for the Blueprint for an AIDS-Free Generation, first announced by Secretary of State Hillary Clinton at the 19th International AIDS Conference. The GAPP advocacy community is a unique coalition of civil society groups, implementing organizations, and faith-based groups.

In Uganda, management of tuberculosis (TB) medicines is fully decentralized. Like other government and private programs, the Ministry of Health’s (MoH) National Tuberculosis and Leprosy Program (NTLP) procured and supplied tuberculosis (TB) medicines independently to district stores.

Dr. Anyo takes staff and interns through a hands-on training exercise during onsite supervision. {Photo credit: Gladys Anyo/MSH.}Photo credit: Gladys Anyo/MSH.

While tuberculosis (TB) is receiving widespread attention in the global health community, many in South Sudan still consider this disease a repulsive affliction and feel uncomfortable associating with TB patients. In addition to fear and discrimination in the general population, the nation’s health professionals often avoid working with TB patients, TB equipment, and sputum samples for fear that they could become infected themselves.

Pages